Thyroid dysfunction induced by anti-PD-1 therapy is associated with a better progression-free survival in patients with advanced carcinoma

PURPOSE: Thyroid dysfunction is the most common immune-related adverse event during anti-programmed cell death 1 (anti-PD-1) therapy. In this study, we monitored patients with advanced malignant tumors who received anti-PD-1 therapy to observe the characteristic of anti-PD-1 therapy-induced thyroid...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yiran, Li, Qingchen, Xu, Lusi, Zheng, Yanqing, Wang, Yanchao, Liu, Ying, Zhang, Rui, Liao, Lin, Dong, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645623/
https://www.ncbi.nlm.nih.gov/pubmed/37715029
http://dx.doi.org/10.1007/s00432-023-05364-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645623/
https://www.ncbi.nlm.nih.gov/pubmed/37715029
http://dx.doi.org/10.1007/s00432-023-05364-z

Ejemplares similares